SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Magellan Health Inc – ‘SC 13E4/A’ on 9/5/96 re: Magellan Health Inc – EX-11.A

As of:  Thursday, 9/5/96   ·   Accession #:  912057-96-19553   ·   File #:  5-05938

Previous ‘SC 13E4’:  ‘SC 13E4/A’ on 8/21/96   ·   Next:  ‘SC 13E4/A’ on 9/9/96   ·   Latest:  ‘SC 13E4/A’ on 10/1/96

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/05/96  Magellan Health Inc               SC 13E4/A              4:38K  Magellan Health Inc               Merrill Corp/FA

Amendment to Tender-Offer Statement — Issuer Tender Offer   —   Schedule 13E-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13E4/A   Amendment to Tender-Offer Statement -- Issuer          8     46K 
                          Tender Offer                                           
 2: EX-11.A     Exhbit (A)(11)                                         4±    19K 
 3: EX-12.A     Exhibit (A)(12)                                        1      6K 
 4: EX-12.B     Exhibit (B)(12)                                        5     18K 


EX-11.A   —   Exhbit (A)(11)

EX-11.A1st “Page” of 2TOCTopPreviousNextBottomJust 1st
 

SUPPLEMENT TO OFFER TO PURCHASE DATED AUGUST 15, 1996 MAGELLAN HEALTH SERVICES, INC. HAS INCREASED ITS OFFER TO PURCHASE FOR CASH TO 3,300,000 SHARES OF ITS COMMON STOCK FROM 1,891,891 SHARES OF ITS COMMON STOCK THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS HAVE BEEN EXTENDED AND WILL NOW EXPIRE AT 12:00 MIDNIGHT, NEW YORK CITY TIME ON WEDNESDAY, SEPTEMBER 18, 1996, UNLESS THE OFFER IS EXTENDED. Magellan Health Services, Inc., a Delaware corporation (the "Company"), pursuant to this Supplement is increasing the number of Shares that it will accept pursuant to the Offer to 3,300,000 Shares from 1,891,891 Shares and is extending the expiration date of the Offer to 12:00 Midnight, New York City time on Wednesday, September 18, 1996, unless the Offer is extended. Capitalized terms used but not defined in this Supplement shall have the meanings assigned to such terms in the Offer to Purchase dated August 15, 1996. -------------------------- Holders who have previously tendered their Shares pursuant to the Offer need not take any further action to tender their Shares. Holders who have not tendered their Shares pursuant to the Offer may continue to use the Letter of Transmittal to tender Shares. -------------------------- THE OFFER IS NOT CONDITIONED UPON ANY MINIMUM NUMBER OF SHARES BEING TENDERED. THE OFFER IS, HOWEVER, SUBJECT TO CERTAIN OTHER CONDITIONS. SEE SECTION 6 OF THE OFFER TO PURCHASE. -------------------------- The Shares are listed and principally traded on the American Stock Exchange, Inc. (the "AMEX") under the symbol "MGL". On September 4, 1996, the closing per Share sales price as reported on the AMEX Composite Tape was $17.125. STOCKHOLDERS ARE URGED TO OBTAIN CURRENT MARKET QUOTATIONS FOR THE SHARES. SEE SECTION 7 OF THE OFFER TO PURCHASE. The Company has been informed by the Depositary that approximately 224,000 Shares have been tendered and not withdrawn as of September 4, 1996. The 3,300,000 Shares that the Company is offering to purchase pursuant to the Offer represent approximately 10.0% of the Shares outstanding as of July 31, 1996. -------------------------- NEITHER THE COMPANY NOR ITS BOARD OF DIRECTORS MAKES ANY RECOMMENDATION TO STOCKHOLDERS AS TO WHETHER TO TENDER OR REFRAIN FROM TENDERING SHARES. THE COMPANY HAS BEEN ADVISED THAT NO DIRECTOR OR EXECUTIVE OFFICER OF THE COMPANY INTENDS TO TENDER ANY SHARES PURSUANT TO THE OFFER. STOCKHOLDERS MUST MAKE THEIR OWN DECISION WHETHER TO TENDER SHARES AND, IF SO, HOW MANY SHARES TO TENDER AND THE PRICE OR PRICES AT WHICH SHARES SHOULD BE TENDERED. -------------------------- If the Company were to purchase 3,300,000 Shares pursuant to the Offer at a Purchase Price of $18.50 per Share (the highest price in the range of possible purchase prices), the maximum aggregate cost of the Offer would be approximately $61.8 million (which includes $700,000 in transaction costs), which would be paid either from borrowings under the Company's Credit Agreement or a combination of borrowings and cash and cash equivalents of the Company. -------------------------- EXCEPT AS OTHERWISE SET FORTH IN THIS SUPPLEMENT, THE TERMS AND CONDITIONS SET FORTH IN THE OFFER TO PURCHASE REMAIN APPLICABLE IN ALL RESPECTS TO THE OFFER. THE INFORMATION SET FORTH HEREIN SHOULD BE READ IN CONJUNCTION WITH THE OFFER TO PURCHASE. -------------------------- Questions and requests for assistance may be directed to, and additional copies of this Supplement, the Offer to Purchase, the Letter of Transmittal or the Notice of Guaranteed Delivery may be obtained from, the Information Agent, MacKenzie Partners, Inc., at (212) 929-5500 (call collect) or (800) 322-2885 (toll-free). -------------------------- THE DEALER MANAGER FOR THE OFFER IS: [DEAN WITTER REYNOLDS LOGO] September 5, 1996
EX-11.ALast “Page” of 2TOC1stPreviousNextBottomJust 2nd
SUMMARY UNAUDITED CONSOLIDATED PRO FORMA FINANCIAL INFORMATION The following summary unaudited consolidated pro forma financial information gives effect to the purchase of the Shares pursuant to the Offer based on certain assumptions described in the Notes to Summary Unaudited Consolidated Pro Forma Financial Information and gives effect to the purchase of the Shares pursuant to the Offer as if it had occurred on October 1, 1994 with respect to the statement of operations data and on September 30, 1995 and June 30, 1996 with respect to the balance sheet data. The summary unaudited consolidated pro forma financial information should be read in conjunction with the summary consolidated historical financial information and does not purport to be indicative of the results that would actually have been obtained had the purchase of the Shares pursuant to the Offer been completed at the dates indicated or that may be obtained in the future. [Enlarge/Download Table] YEAR ENDED SEPTEMBER 30, 1995 NINE MONTHS ENDED JUNE 30, 1996 ------------------------------------------ ------------------------------------------- PRO FORMA PRO FORMA ------------------------------ ------------------------------ ASSUMED $18.50 ASSUMED $16.50 ASSUMED $18.50 ASSUMED $16.50 PER SHARE PER SHARE UNAUDITED PER SHARE PER SHARE HISTORICAL PURCHASE PRICE PURCHASE PRICE HISTORICAL PURCHASE PRICE PURCHASE PRICE ---------- -------------- -------------- ----------- -------------- -------------- (IN THOUSANDS, EXCEPT RATIOS AND PER SHARE AMOUNTS) STATEMENT OF OPERATIONS DATA: Net revenue....................... $1,151,736 $1,151,736 $1,151,736 $ 996,997 $ 996,997 $ 996,997 Net income (loss)................. (42,963) (45,898) (45,584) 24,095 22,051 22,270 Net income (loss) per common share............................ $ (1.54) $ (1.87) $ (1.86) $ 0.79 $ 0.81 $ 0.82 Average number of shares outstanding...................... 27,870 24,570 24,570 30,559 27,259 27,259 Ratio (deficiency) of earnings before fixed charges to fixed charges.......................... $ (54,085) $ (58,977) $ (58,454) 1.93 1.81 1.82 [Enlarge/Download Table] AS OF SEPTEMBER 30, 1995 AS OF JUNE 30, 1996 ------------------------------------------- ------------------------------------------ PRO FORMA PRO FORMA ------------------------------ ------------------------------ ASSUMED $18.50 ASSUMED $16.50 ASSUMED $18.50 ASSUMED $16.50 PER SHARE PER SHARE UNAUDITED PER SHARE PER SHARE HISTORICAL PURCHASE PRICE PURCHASE PRICE HISTORICAL PURCHASE PRICE PURCHASE PRICE ----------- -------------- -------------- ---------- -------------- -------------- (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS) BALANCE SHEET DATA: Working Capital................... $ 91,413 $ 91,413 $ 91,413 $ 115,029 $ 115,029 $ 115,029 Total Assets...................... 983,558 983,558 983,558 1,170,187 1,170,187 1,170,187 Total assets less goodwill and reorganization value in excess of amounts allocable to identifiable assets........................... 943,564 943,564 943,564 1,041,319 1,041,319 1,041,319 Long-term debt and capital lease obligations...................... 538,770 600,520 593,920 532,100 593,850 587,250 Stockholders' equity.............. 88,560 26,810 33,410 185,715 123,965 130,565 Book value per common share....... 3.17 1.09 1.36 5.72 4.25 4.48 ------------------------ NOTES TO SUMMARY UNAUDITED CONSOLIDATED PRO FORMA INFORMATION The following assumptions regarding the Offer were made in determining the pro forma financial information: (1) The information assumes 3,300,000 Shares are purchased at $16.50 per share and $18.50 per share with the purchase being financed under the Company's Credit Agreement bearing interest at 7.92% in fiscal 1995 and 7.48% for the nine months ended June 30, 1996. (2) Expenses directly related to the Offer are assumed to be $700,000 and are included as part of the cost of the Shares acquired. (3) The ratio (deficiency) of earnings before fixed charges to fixed charges were computed by dividing pre-tax income before fixed charges by fixed charges. Fixed charges consist of interest expense and the interest component of operating leases. (4) Book value per common share is calculated as total stockholders' equity divided by the number of common shares outstanding, net of treasury shares, at the end of the period. MAGELLAN HEALTH SERVICES, INC.

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13E4/A’ Filing    Date First  Last      Other Filings
9/18/961SC 13E4/A
Filed on:9/5/961
9/4/961
8/15/961SC 13E4
7/31/961
6/30/96210-Q
9/30/95210-K,  10-K/A
10/1/942
 List all Filings 
Top
Filing Submission 0000912057-96-019553   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 5:38:18.1am ET